Bacillus Calmette Guerin, effective drug in intravesical treatment of superficial bladder tumors
Keywords:
urinary bladder neoplasms/drug therapy, BCG vaccine/therapeutic use, administration, intravesicalAbstract
The Bacillus Calmette Guerin is the drug most likely to be administered for intravesical therapy in patients with superficial bladder tumors in the Urology Department of the Arnaldo Milian Castro Provincial University Hospital in Villa Clara. The objectives of this literature review are to transmit knowledge to the medical staff, nurses and patients about Bacillus Calmette Guerin in the adjuvant treatment of superficial bladder tumors with surgical removal of the tumor by transurethral resection in order to improve the medical services received by these patients, provide information to the patient receiving treatment, avoid uncertainty in the management of their disease and positively influence the right treatment compliance to achieve maximum effectiveness of this drug in this disease. The Bacillus Calmette Guerin is an effective medication, safe and feasible in our milieu for intravesical immunotherapy of patients with superficial bladder tumors. It improves the quality of life of patients in the disease process by reducing the number of relapses of this tumor, but this requires adequate scientific information by health staff on management and use of Bacillus that allows, therefore, providing quality health care and improving the health services of our institution.Downloads
Downloads
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms:
- Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
- Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
- Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).